These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
279 related items for PubMed ID: 6176788
1. Roles of endogenous prostacyclin and thromboxane A2 in the ischemic canine heart. Sakai K, Ito K, Ogawa K. J Cardiovasc Pharmacol; 1982; 4(1):129-35. PubMed ID: 6176788 [Abstract] [Full Text] [Related]
2. Reduction of prostacyclin synthesis as a possible cause of transient flow reduction in a partially constricted canine coronary artery. Tada M, Esumi K, Yamagishi M, Kuzuya T, Matsuda H, Abe H, Uchida Y, Murao S. J Mol Cell Cardiol; 1984 Dec; 16(12):1137-49. PubMed ID: 6398370 [Abstract] [Full Text] [Related]
3. The effect of a thromboxane synthetase inhibitor, OKY-046, on urinary excretion of immunoreactive thromboxane B2 and 6-keto-prostaglandin F1 alpha in patients with ischemic cerebrovascular disease. Uyama O, Nagatsuka K, Nakabayashi S, Isaka Y, Yoneda S, Kimura K, Abe H. Stroke; 1985 Dec; 16(2):241-4. PubMed ID: 3883580 [Abstract] [Full Text] [Related]
4. Comparison of umbilical vein models for measurement of relative prostacyclin and thromboxane production. Mehta P, Mehta J, Crews F, Roy L, Ostrowski N, Horalek C. Prostaglandins; 1982 Dec; 24(6):743-9. PubMed ID: 6820165 [Abstract] [Full Text] [Related]
5. Inhibition of cyclic flow variations in stenosed canine coronary arteries by thromboxane A2/prostaglandin H2 receptor antagonists. Ashton JH, Schmitz JM, Campbell WB, Ogletree ML, Raheja S, Taylor AL, Fitzgerald C, Buja LM, Willerson JT. Circ Res; 1986 Nov; 59(5):568-78. PubMed ID: 3542279 [Abstract] [Full Text] [Related]
6. [Experimental study on the pathophysiology of endotoxin shock as analysed by alterations in thromboxane B2 and 6-keto-PGF1 alpha levels]. Baba H. Nihon Geka Gakkai Zasshi; 1988 Jan; 89(1):6-20. PubMed ID: 3283521 [Abstract] [Full Text] [Related]
7. Role of prostaglandin I2 and thromboxane A2 in recurring reduction of carotid and cerebral blood flow in dogs. Uchida Y, Murao S. Stroke; 1981 Jan; 12(6):786-92. PubMed ID: 7029792 [Abstract] [Full Text] [Related]
8. Long-term myocardial preservation: thromboxane production and coronary resistance. van Rijk GL, Foegh M, Ramwell PW, Goldman M, Lower RR. J Surg Res; 1983 Nov; 35(5):417-20. PubMed ID: 6688844 [Abstract] [Full Text] [Related]
10. Assessment of prostacyclin and thromboxane A2 release during reperfusion after global ischemia induced by crystalloid cardioplegia--comparison between warm and cold ischemia. Nomura F, Matsuda H, Hirose H, Shirakura R, Ohtani M, Kaneko M, Kawashima Y. Eur Surg Res; 1988 Sep; 20(2):110-9. PubMed ID: 3292253 [Abstract] [Full Text] [Related]
11. Endogenous prostaglandin endoperoxides and prostacyclin modulate the thrombolytic activity of tissue plasminogen activator. Effects of simultaneous inhibition of thromboxane A2 synthase and blockade of thromboxane A2/prostaglandin H2 receptors in a canine model of coronary thrombosis. Golino P, Rosolowsky M, Yao SK, McNatt J, De Clerck F, Buja LM, Willerson JT. J Clin Invest; 1990 Oct; 86(4):1095-102. PubMed ID: 2145320 [Abstract] [Full Text] [Related]
12. Effect of ischemic skin flap elevation on tissue and plasma thromboxane A2 and prostacyclin production: modification by thromboxane synthetase inhibition. Edstrom LE, Balkovich M, Slotman GJ. Ann Plast Surg; 1988 Feb; 20(2):106-11. PubMed ID: 3281544 [Abstract] [Full Text] [Related]
13. Effects of selective thromboxane synthetase inhibitor and indomethacin on prostacyclin and thromboxane A2 from ischemic canine heart. Ogawa K, Sakai K, Ito T, Watanabe J, Satake T. Adv Prostaglandin Thromboxane Leukot Res; 1983 Feb; 11():371-6. PubMed ID: 6221548 [No Abstract] [Full Text] [Related]
14. Experimental coronary artery thrombosis in the absence of thromboxane A2 synthesis: evidence for alternate pathways for coronary thrombosis. Hook BG, Schumacher WA, Lee DL, Jolly SR, Lucchesi BR. J Cardiovasc Pharmacol; 1985 Feb; 7(1):174-81. PubMed ID: 2580139 [Abstract] [Full Text] [Related]
15. Effect of vacuum curettage on the concentrations of plasma 6-keto-prostaglandin F1 alpha and serum thromboxane B2. Ylikorkala O, Mäkilä UM, Viinikka L. Br J Obstet Gynaecol; 1983 Mar; 90(3):251-4. PubMed ID: 6338904 [Abstract] [Full Text] [Related]
16. Inhibition of coronary circulatory failure and thromboxane A2 release during coronary occlusion and reperfusion by 2-phenylaminoadenosine (CV-1808) in anesthetized dogs. Tanabe M, Terashita Z, Nishikawa K, Hirata M. J Cardiovasc Pharmacol; 1984 Mar; 6(3):442-8. PubMed ID: 6202970 [Abstract] [Full Text] [Related]
17. [Beneficial effect of a selective TXA2 synthetase inhibitor, OKY-046, both on thromboxane B2 production and vascular damage after spinal cord injury in rat spinal cord]. Morimoto K, Ikata T, Tounai T. Nihon Seikeigeka Gakkai Zasshi; 1990 Jan; 64(1):82-8. PubMed ID: 2319197 [Abstract] [Full Text] [Related]
18. Effects of a thromboxane synthetase inhibitor and a thromboxane antagonist on release and activity of thromboxane A2 and prostacyclin in vitro. O'Keefe EH, Liu EC, Greenberg R, Ogletree ML. Prostaglandins; 1985 May; 29(5):785-97. PubMed ID: 3925501 [Abstract] [Full Text] [Related]
19. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides. Mehta J, Mehta P, Lawson DL, Ostrowski N, Brigmon L. J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780 [Abstract] [Full Text] [Related]
20. Increased prostacyclin and thromboxane production in man during cardiopulmonary bypass. Ylikorkala O, Saarela E, Viinikka L. J Thorac Cardiovasc Surg; 1981 Aug; 82(2):245-7. PubMed ID: 7019583 [Abstract] [Full Text] [Related] Page: [Next] [New Search]